AGŐćČ˹ٷ˝

STOCK TITAN
  1. Home
  2. Sec-filings
  3. MNKD
  4. [Form 4] Mannkind Corporation Insider Trading Activity

[Form 4] Mannkind Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock MNKD logo
Mannkind

NASDAQ:MNKD

MNKD Rankings

#3486 Ranked by Market Cap
N/A Ranked by Dividends
#117 Top Loser

MNKD Latest News

Aug 6, 2025
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
Aug 6, 2025
MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update
Jul 30, 2025
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025
Jun 9, 2025
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23
May 27, 2025
INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29

MNKD Latest SEC Filings

Aug 6, 2025
[10-Q] Mannkind Corporation Quarterly Earnings Report
Aug 6, 2025
[8-K] Mannkind Corporation Reports Material Event
Jul 17, 2025
[Form 4] Mannkind Corporation Insider Trading Activity
Jul 17, 2025
[Form 4] Mannkind Corporation Insider Trading Activity
Jul 17, 2025
[Form 4] Mannkind Corporation Insider Trading Activity

MNKD Stock Data

1.14B
298.60M
1.67%
58.72%
7.82%
Biotechnology
Pharmaceutical Preparations
United States
DANBURY